Sutro Biopharma
STRO
#9556
Rank
$72.32 M
Marketcap
$8.49
Share price
-0.06%
Change (1 day)
202.14%
Change (1 year)

Revenue for Sutro Biopharma (STRO)

Revenue in 2025 (TTM): $0.10 Billion USD

According to Sutro Biopharma's latest financial reports the company's current revenue (TTM ) is $0.10 Billion USD. In 2024 the company made a revenue of $62.04 Million USD a decrease over the revenue in the year 2023 that were of $0.15 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sutro Biopharma from 2018 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $0.10 B70.28%
2024 $62.04 M-59.64%
2023 $0.15 B126.84%
2022 $67.77 M9.52%
2021 $61.88 M44.84%
2020 $42.72 M-0.03%
2019 $42.73 M11.24%
2018 $38.41 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
$0.22 M-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
$0.64 B 507.75%๐Ÿ‡บ๐Ÿ‡ธ USA